Table 1.
Overall survival | Disease-free survival | |||||
---|---|---|---|---|---|---|
HR | 95%CI | P value | HR | 95%CI | P value | |
Risk | ||||||
Low | ||||||
High | 2.890 | 1.747-4.782 | 0.000 | 2.053 | 1.429-2.949 | 0.000 |
Age | 1.020 | 1.001-1.038 | 0.035 | 1.010 | 0.998-1.023 | 0.113 |
Sex | ||||||
Female | ||||||
Male | 0.903 | 0.563-1.448 | 0.672 | 1.090 | 0.767-1.548 | 0.632 |
Race | ||||||
Asian | ||||||
Black | 0.713 | 0.082-6.219 | 0.759 | 2.122 | 0.264-17.028 | 0.479 |
White | 0.537 | 0.073-3.974 | 0.543 | 1.913 | 0.266-13.781 | 0.520 |
Histological type | ||||||
Dedifferentiated liposarcoma | ||||||
Leiomyosarcoma | 0.774 | 0.435-1.377 | 0.383 | 0.796 | 0.512-1.238 | 0.311 |
Myxofibrosarcoma | 0.686 | 0.288-1.633 | 0.394 | 0.735 | 0.378-1.430 | 0.365 |
Other | 0.678 | 0.252-1.818 | 0.440 | 0.702 | 0.345-1.430 | 0.330 |
Undifferentiated pleomorphic sarcoma | 0.664 | 0.300-1.470 | 0.312 | 0.775 | 0.439-1.369 | 0.381 |
Metastasis | ||||||
No | ||||||
Yes | 4.878 | 2.550-9.329 | 0.000 | 4.937 | 3.140-7.762 | 0.000 |
Radiotherapy | ||||||
No | ||||||
Yes | 1.255 | 0.723-2.176 | 0.419 | 1.169 | 0.784-1.744 | 0.444 |
Margin status | ||||||
R0 | ||||||
R1-2 | 2.328 | 1.396-3.883 | 0.001 | 2.085 | 1.422-3.056 | 0.000 |
Tumor site | ||||||
Extremity | ||||||
Other | 1.160 | 0.695-1.936 | 0.570 | 0.974 | 0.6731.410 | 0.891 |
Multifocal indicator | ||||||
No | ||||||
Yes | 2.605 | 1.503-4.516 | 0.001 | 2.081 | 1.313-3.298 | 0.002 |
HR, hazard ratio; CI, confidence interval.